Ruben, tell us what you did and what you found.

Thank you, Professor Gibson, for the introduction.

And first of all, I would like to say I'm honored to be able to discuss the first results of the PROC-TO trial today here with you and naturally on behalf of the PROC-TO trial investigators.

Well, I think the PROC-TO trial is about some of the key challenges that we face in managing post-catch patients.

We know that long-term efficacy of bypass graft surgery is limited by both bypass graft failure and progression of disease in the native coronary arteries.

And as a result, there's a substantial number of patients that present with recurrent angina symptoms and ischemia affecting up to six out of 10 patients at 15 years after bypass surgery.

And many of these patients return to the cath lab for repeat coronary angiography and further revascularization therapy.

Are you surprised by the results?